The Possible Pathophysiological Role of Pancreatic Stone Protein in Sepsis and Its Potential Therapeutic Implication
Open Access
- 7 August 2024
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 12 (8) , 1790
Abstract
According to the current understanding of the pathophysiology of sepsis, key host dysregulated responses leading to organ failure are mediated by innate immunity, through interactions between pathogen-associated molecular patterns (PAMPs) and damaged-associated molecular patterns (DAMPs) binding to four types of pattern recognition receptors (PRRs). PRRs activation triggers the protein kinase cascade, initiating the cellular response seen during sepsis. Pancreatic stone protein (PSP), a C-type lectin protein, is a well-defined biomarker of sepsis. Studies have shown that stressed and immune-activated pancreatic β-cells secrete PSP. Animal studies have shown that PSP injection aggravates sepsis, and that the disease severity score and mortality were directly correlated with the doses of PSP injected. In humans, studies have shown that PSP activates polymorphonuclear neutrophils (PMNs) and aggravates multiple organ dysfunction syndrome. Clinical studies have shown that PSP levels are correlated with disease severity, vasopressor support, progression to organ failure, mechanical ventilation, renal replacement therapy, length of stay, and mortality. As PSP is a C-type lectin protein, it may have a role in activating innate immunity through the C-type lectin receptors (CLRs), which is one of the four PRRs. Herein, we review the literature on PSP and its possible role in the pathophysiology of sepsis, and we discuss its potential therapeutic role.Keywords
This publication has 48 references indexed in Scilit:
- International Consensus Criteria for Pediatric Sepsis and Septic ShockJAMA, 2024
- Discriminative performance of pancreatic stone protein in predicting ICU mortality and infection severity in adult patients with infection: a systematic review and individual patient level meta-analysisInfection, 2023
- Type 2 diabetes mellitus and sepsis: state of the art, certainties and missing evidenceActa Diabetologica, 2021
- Expression of Pancreatic Stone Protein is Unaffected by Trauma and Subsequent Surgery in Burn PatientsWorld Journal of Surgery, 2020
- Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in childrenIntensive Care Medicine, 2020
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe SepsisJAMA, 2013
- Measurement of serum PSP/reg-protein concentration in various diseases with a newly developed enzyme-linked immunosorbent assayJournal of Gastroenterology, 1995
- Serum pancreatic stone protein in pancreatic diseasesInternational journal of pancreatology, 1993
- Enzyme immunoassay and characterization of pancreatic stone proteins in human urineJournal of Clinical Laboratory Analysis, 1993